Seuss+

Is AI revolutionizing biotech, or is it just hype? In our latest Cut the Chat Life Science Insider episode, titled: AI in Biotech: Hype, Reality, and the Future of Drug Development. Seuss+ CEO and Co-Founder Sabine Hutchison sits down with AI thought leader Christina Busmalis to explore how AI is shaping drug discovery and clinical trials while also addressing the challenges of proving its real-world effectiveness. - Can AI truly accelerate drug development? - What is the actual impact on clinical trials? If you’re curious about AI’s future role in healthcare, don’t miss this insightful discussion. Listen here: https://lnkd.in/ejjkEewG #AI #Biotech #DrugDevelopment #Healthcare #Innovation

Thanks for the reshare Pascal Sempé. It was an absolute pleasure to highlight such an important topic with Christina Busmalis. Glad to see this message resonating—The integration of #AI in #drugdevelopment brings incredible potential, but it’s the collaboration between tech experts and scientists that ensures real progress. If you haven't tuned in yet, get the full episode here: https://lnkd.in/ejjkEewG

With 65% of clinical trial budgets going to vendors, the stakes for navigating the vendor landscape have never been higher. It’s more than just finding a partner—it’s understanding the market, vetting capabilities, and aligning vendor potential with clinical goals before selection even starts. Here’s what every biotech sponsor needs to know to navigate the pre-selection phase effectively. https://hubs.ly/Q02S76Vl0 #biotechlandscape #clinicaldevelopment #vendorselection #biopharma

65% of clinical trial budgets are tied to vendors, yet choosing the right ones begins long before selection. Navigating a landscape crowded with vendors, services, and new capabilities is essential for sponsors to get a clear view of who can truly support their goals. Discover strategies for finding value and alignment in the sea of vendor options. https://hubs.ly/Q02S770H0 #biotechstrategy #clinicaldevelopment #vendorlandscape #biopharma #clinicaltrials

As a biotech company driving innovative therapies, you need a partner that understands your unique challenges. That’s why Seuss+ has refined its approach to meet your exact needs. From selecting the right vendors to managing trial risks and preparing for regulatory inspections, our updated services are designed to maximize your vendor relationships so you can move through clinical development faster and with more confidence. We’ve refined our Vendor Relationship Maximization Method (VRMM) specifically for small to mid-sized companies like yours, ensuring that every partnership drives success. Are you ready to optimize your vendor relationships? https://hubs.ly/Q02S76V60 #Biotech #Pharma #ClinicalTrials #VendorManagement #ClinicalDevelopment

Effective clinical trials demand seamless vendor collaboration. We empower sponsors to optimize each phase of development by maximizing vendor relationships. Through our Vendor Relationship Maximization Method (VRMM), we ensure alignment, quality oversight, and clear communication for more efficient and compliant trials. Discover how our evolved approach is setting new standards in clinical success. https://hubs.ly/Q02S9GYC0 #ClinicalDevelopment #VendorStrategy #PharmaExcellence #BiotechSolutions #TrialSuccess #SeussPlus #EfficientTrials

Small and mid-sized biotech companies like yours face intense pressure to deliver results, often with limited resources. That’s why we’ve pivoted at Seuss+—to focus on what matters most to you. Fewer delays minimized risks, and smoother clinical trials. We’re here to partner with you every step of the way. Let’s align your vendor relationships to drive success. https://hubs.ly/Q02S76kF0 #Biotech #Pharma #ClinicalTrials #VendorManagement #ClinicalDevelopment

We are redefining vendor relationships, recognizing them as key drivers in clinical success. With our Vendor Relationship Maximization Method (VRMM), sponsors gain structured, end-to-end support—from the first alignment to quality assurance. Learn how Seuss+ is helping sponsors streamline vendor partnerships for more efficient, compliant trials. https://hubs.ly/Q02S9MWX0 #VendorOptimization #ClinicalSuccess #SeussPlus #ClinicalTrials #PharmaPartnerships #BiotechInnovation #VRMM #ClinicalCompliance

At Seuss+, we know that managing a lean team while moving clinical trials forward isn’t easy. You’re juggling tight timelines, vendor coordination, and regulatory pressure. We get it, and we’ve refined our services to help. We’ve evolved to meet your needs with a sharper focus on maximizing vendor partnerships. Whether it’s vendor strategy, risk management, or inspection readiness, we’ll work with you to streamline your processes and reduce delays. https://hubs.ly/Q02S76_x0 #Biotech #Pharma #ClinicalTrials #VendorManagement #ClinicalDevelopment

Welcome to the October Seuss+ Newsletter! As the life sciences industry adapts to new guidance from global authorities like the WHO and FDA, Seuss+ is also evolving to better support the needs of our clients. We’re sharpening our focus on aligning stakeholders at every stage of clinical development—from optimizing vendor relationships to streamlining operational compliance. This month’s updates touch on recent regulatory shifts affecting clinical trial design and the critical role of alignment in biotech-CRO partnerships.   Thank you for reading and being part of this journey with us!